查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143480

膠囊型感冒藥市場：全球市場預測（2026-2032年）

Capsule Cold Medicine Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，膠囊型感冒藥市場規模將達到 439.3 億美元，複合年成長率為 5.07%。

主要市場統計數據
基準年 2025 310.6億美元
預計年份：2026年 323.1億美元
預測年份 2032 439.3億美元
複合年成長率 (%) 5.07%

膠囊型感冒藥：執行摘要

膠囊型感冒藥屬於非處方呼吸道照護產品類型，消費者通常尋求能夠便捷緩解鼻塞、咳嗽、喉嚨痛、發燒及其他相關不適症狀的產品。產品差異化取決於活性成分、劑型、標籤清晰度、藥劑師指導以及是否符合國家藥品法規。市場需求受季節性疾病流行模式、消費者自我護理行為、醫療保健服務可近性以及公眾對合理用藥的認知等因素的影響。

便利性、安全性和法規正在改變類別的定義方式。

市場環境正朝著更人性化的劑型、更清晰的使用說明以及對負責任的自我治療的更高重視方向發展。隨著消費者擴大透過數位管道比較產品，零售商和藥房則優先考慮產品的可及性、包裝資訊以及對不同年齡層和健康狀況的適用性。由於複方製劑可能包含多種活性成分，因此透明的標籤、禁忌症指南以及防止重複用藥的安全措施至關重要，監管仍然必不可少。

人工智慧可以改善產品發現、指導和營運。

人工智慧 (AI) 可以輔助進行需求預測、庫存規劃、客戶服務優先排序，並分析呼吸照護的常見問題。它還可以識別不清晰的標籤、改進多語言宣傳活動，並偵測異常購買模式或不利事件模式，以便進行進一步的人工核實。然而，AI 產生的健康指導需要臨床監督、資料檢驗、隱私控制和明確的界限，以確保症狀管理資訊不會取代專業診斷或緊急醫療救治。

區域洞察：季節性和可及性差異

北美地區擁有成熟的藥局和零售體系，消費者對非處方藥（OTC）的熟悉程度也較高。而拉丁美洲則存在購買力差異、非正規通路分銷風險、監管執法力度不一等問題。歐洲重視藥品核准、安全資訊傳播和統一標準，但各國藥局的營運實務仍有差異。中東地區受都市區藥局的可近性、進口產品要求以及氣候相關的購買模式等因素的影響。非洲由於醫療保健資源取得和供應鏈可靠性方面存在顯著差異，因此藥品價格可負擔性、品質保證和藥劑師教育尤為重要。亞太地區擁有發達的自我護理市場，都市區和數位管道也在快速發展，但其特徵是季節性因素、監管法規和消費者健康素養方面存在顯著差異。

群體特定洞察：經濟和監管障礙影響准入

東協市場法規環境多元，疾病模式與熱帶和季風季節相關，跨國貿易不斷成長。金磚國家人口眾多且構成複雜，其優先事項涵蓋國內生產和藥品可負擔性、零售現代化以及監管能力等多個面向。歐盟強調協調一致的安全框架，同時保留各國在藥品分發和消費者資訊上的差異。七國集團市場通常具有完善的藥房基礎設施、健全的產品監管體係以及對循證標籤的高期望。海灣合作理事會市場的特點是部分地區實施集中採購、進口產品受到監管以及需求集中在都市區。北約成員國的醫療保健體系各不相同，但對災害防備的通用關注可能會促使各國更加重視具有韌性的藥品供應鏈和公共衛生資訊傳播。

主要消費市場和受監管市場的國家洞察

在澳大利亞，重點在於藥屋主導的諮詢、清晰的標籤以及呼吸系統護理的季節性需求。巴西和墨西哥擁有廣泛的零售網路，但價格範圍和分銷條件因地區而異。加拿大和美國藥房和電子商務管道普及，同時對成分和消費者資訊進行嚴格審查。中國和印度擁有龐大且多元化的消費群體，都市化、在地化生產和數位商務影響著藥品的取得。在日本和韓國，重點在於產品品質、便利性和詳細的使用指南。法國、德國、義大利和西班牙在歐洲監管原則的框架內運作，同時維持各自的藥房體系和保險報銷制度。英國也同樣將成熟的藥局管道與對安全資訊提供的高期望結合。俄羅斯的特點是國內供應充足、監管要求嚴格以及分銷條件因地區而異。

領導重點：建立信任、韌性和負責任的自我護理。

業界領導者應以簡潔明了的方式傳達活性成分訊息，醒目地標示重複用藥警告，並採用易於理解的包裝設計。他們也應加強對藥劑師和消費者的教育，尤其關注兒童、老年人、孕婦、慢性疾病患者以及與其他藥物的相互作用。供應鏈規劃應多元化合格供應商，保持可追溯性，並利用數據進行庫存補貨，同時確保符合管治。數位化互動應提供循證訊息，在症狀嚴重或持續存在時引導患者尋求專科醫療服務，並透過安全性、申訴和依從率等指標以及推廣覆蓋範圍來衡量效果。

調查方法：對類別促進因素進行結構化檢討。

本執行摘要採用定性且基於證據的框架，對膠囊型感冒藥進行評估。評估內容包括產品配方、症狀緩解應用案例、監管和標籤要求、藥局和零售店的供應、線上購買行為、醫療基礎設施、季節性、價格負擔能力以及供應鏈韌性。本概要也提供了區域、群體和國家層面的比較，以便對這些因素進行背景解讀。本概要不包含市場估算、預測、市場佔有率、預測結果或公司特定聲明。在做出實際決策之前，應根據現行的國家監管文件、臨床指南、監測數據以及銷售管道研究來檢驗結論的有效性。

結論：透過清晰的溝通、優質的產品和消費者的信任贏得競爭。

膠囊型感冒藥仍然是一種以便利性為主導的自我護理品類，其成功不僅取決於症狀緩解的需求。選擇安全的配方、清晰的標籤、可靠的供應、負責任的數位化溝通以及遵守當地法規，對於永續的市場准入至關重要。那些將以消費者為中心的設計理念與嚴格的品管系統、強大的分銷網路和精心管理的數據分析相結合的領導企業，將更有能力支持消費者合理用藥，同時滿足不同地區和人群的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 膠囊型感冒藥市場：依活性成分分類

  • 複方製劑
    • 乙醯胺酚，氯苯那敏
    • 乙醯胺酚苯腎上腺素
    • Ibuprofen苯腎上腺素
  • 單一成分
    • 乙醯胺酚
    • 撲爾敏
    • Ibuprofen
    • 苯海拉明

第8章：膠囊型感冒藥市場：依劑量強度分類

  • 高劑量（500毫克以上）
  • 低劑量 0-200 毫克
  • 中等劑量 201-500 毫克

第9章：膠囊型感冒藥市場：依通路分類

  • 便利商店
  • 線上零售
  • 藥局
    • 連鎖藥局
    • 獨立經營藥房
  • 超級市場和大賣場

第10章：膠囊型感冒藥市場：依最終用戶分類

  • 成人
  • 老年人
  • 兒童

第11章 膠囊型感冒藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 膠囊型感冒藥市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 膠囊型感冒藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Bayer Aktiengesellschaft
  • Boehringer Ingelheim International GmbH
  • Captek Softgel International Inc.
  • Fuji Capsule Co. Ltd.
  • Haleon PLC
  • Johnson & Johnson
  • Novartis AG
  • Perrigo Company plc
  • Reckitt Benckiser Group plc
  • Robinson Pharma Inc.
  • Sanofi SA
  • Soft Gel Technologies Inc.
  • Sun Pharmaceutical Industries Ltd
  • The Procter & Gamble Company

第16章 主要專家

Product Code: MRR-9C4233EE7CF0

The Capsule Cold Medicine Market is projected to grow by USD 43.93 billion at a CAGR of 5.07% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 31.06 billion
Estimated Year [2026] USD 32.31 billion
Forecast Year [2032] USD 43.93 billion
CAGR (%) 5.07%

Capsule Cold Medicine: Executive Summary

Capsule cold medicines are positioned within the broader over-the-counter respiratory-care category, where consumers typically seek convenient symptom relief for congestion, cough, sore throat, fever, and related discomfort. Product differentiation is shaped by active-ingredient combinations, dosage formats, labeling clarity, pharmacist guidance, and compliance with national medicine regulations. Demand conditions vary with seasonal illness patterns, consumer self-care behavior, healthcare access, and public understanding of appropriate medicine use.

Convenience, Safety, and Regulation Are Reshaping the Category

The landscape is shifting toward easier-to-use formats, clearer dosing instructions, and stronger attention to responsible self-medication. Consumers increasingly compare products through digital channels, while retailers and pharmacies emphasize availability, package information, and suitability for different age groups and health conditions. Regulatory scrutiny remains important because combination products can contain multiple active ingredients, creating a need for transparent labeling, contraindication guidance, and safeguards against duplicate dosing.

Artificial Intelligence Improves Discovery, Guidance, and Operations

Artificial intelligence can support demand sensing, inventory planning, customer-service triage, and analysis of recurring respiratory-care questions. It may also help identify confusing label language, improve multilingual education, and detect unusual purchasing or adverse-event patterns for further human review. However, AI-generated health guidance requires clinical oversight, validated data, privacy controls, and clear boundaries so that symptom-management information does not substitute for professional diagnosis or emergency care.

Regional Insights: Diverse Seasonality and Access Conditions

North America combines mature pharmacy and retail systems with strong consumer familiarity with over-the-counter medicines, while Latin America reflects varied purchasing power, informal distribution risks, and differences in regulatory enforcement. Europe places substantial emphasis on authorization, safety communication, and harmonized standards, although national pharmacy practices still differ. The Middle East is influenced by urban pharmacy access, imported-product requirements, and climate-related purchasing patterns. Africa presents highly varied healthcare access and supply-chain reliability, making affordability, quality assurance, and pharmacist education especially important. Asia-Pacific includes advanced self-care markets alongside rapidly expanding urban and digital channels, with significant variation in seasonal exposure, regulation, and consumer health literacy.

Group Insights: Economic and Regulatory Blocs Shape Access

ASEAN markets present diverse regulatory environments, tropical and monsoon-related illness patterns, and growing cross-border commerce. BRICS economies span large and varied populations, with priorities ranging from domestic manufacturing and affordability to retail modernization and regulatory capacity. The European Union emphasizes coordinated safety frameworks while retaining national differences in dispensing and consumer communication. G7 markets generally feature developed pharmacy infrastructure, robust product oversight, and high expectations for evidence-based labeling. GCC markets are shaped by centralized procurement in some settings, imported-product controls, and concentrated urban demand. NATO members encompass diverse health systems, but shared preparedness concerns can increase attention to resilient medicine supply chains and public-health communication.

Country Insights Across Major Consumer and Regulatory Markets

Australia emphasizes pharmacy-led advice, clear labeling, and seasonal respiratory-care demand. Brazil and Mexico combine broad retail reach with varied affordability and distribution conditions. Canada and the United States have extensive pharmacy and e-commerce access, alongside strong scrutiny of combination ingredients and consumer information. China and India contain large, diverse consumer bases where urbanization, local manufacturing, and digital commerce influence access. Japan and South Korea place high value on product quality, convenience, and detailed usage guidance. France, Germany, Italy, and Spain operate within European regulatory principles while retaining distinct pharmacy and reimbursement practices. The United Kingdom similarly combines established pharmacy channels with strong expectations for safety communication. Russia is shaped by domestic availability, regulatory requirements, and regional distribution differences.

Priorities for Leaders: Build Trust, Resilience, and Responsible Self-Care

Industry leaders should simplify active-ingredient communication, use prominent warnings against duplicate dosing, and design packaging for rapid comprehension. They should strengthen pharmacist and consumer education, especially for children, older adults, pregnancy, chronic conditions, and interactions with other medicines. Supply-chain plans should diversify qualified sources, maintain traceability, and use data-assisted replenishment without compromising governance. Digital engagement should provide evidence-based information, direct users toward professional care when symptoms are serious or persistent, and measure outcomes through safety, complaint, and adherence indicators rather than promotional reach alone.

Research Methodology: Structured Review of Category Drivers

This executive summary uses a qualitative, evidence-oriented framework for capsule cold medicine. The assessment considers product format, symptom-relief use cases, regulatory and labeling requirements, pharmacy and retail access, digital purchasing behavior, healthcare infrastructure, seasonality, affordability, and supply-chain resilience. Regional, group, and country comparisons are presented as contextual interpretations of these drivers. No market estimates, market shares, forecasts, or company-specific claims are included; conclusions should be validated against current national regulatory documents, clinical guidance, surveillance data, and channel research before operational decisions are made.

Conclusion: Compete Through Clarity, Quality, and Consumer Confidence

Capsule cold medicine remains a convenience-led self-care category whose performance depends on more than symptom demand. Safe formulation choices, understandable labels, dependable availability, responsible digital communication, and alignment with local regulation are central to sustainable participation. Leaders that combine consumer-centric design with rigorous quality systems, resilient distribution, and carefully governed analytics will be better positioned to serve varied regional and demographic needs while supporting appropriate and informed medicine use.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Capsule Cold Medicine Market, by Active Ingredient

  • 7.1. Introduction
  • 7.2. Combination Formulation
    • 7.2.1. Acetaminophen Chlorpheniramine
    • 7.2.2. Acetaminophen Phenylephrine
    • 7.2.3. Ibuprofen Phenylephrine
  • 7.3. Single Ingredient
    • 7.3.1. Acetaminophen
    • 7.3.2. Chlorpheniramine
    • 7.3.3. Ibuprofen
    • 7.3.4. Phenylephrine

8. Capsule Cold Medicine Market, by Dosage Strength

  • 8.1. Introduction
  • 8.2. High Dose >500 Mg
  • 8.3. Low Dose 0-200 Mg
  • 8.4. Medium Dose 201-500 Mg

9. Capsule Cold Medicine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Convenience Store
  • 9.3. Online Retail
  • 9.4. Pharmacy
    • 9.4.1. Chain Pharmacy
    • 9.4.2. Independent Pharmacy
  • 9.5. Supermarket Hypermarket

10. Capsule Cold Medicine Market, by End User

  • 10.1. Introduction
  • 10.2. Adult
  • 10.3. Geriatric
  • 10.4. Pediatric

11. Capsule Cold Medicine Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Capsule Cold Medicine Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Capsule Cold Medicine Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Bayer Aktiengesellschaft
  • 15.2. Boehringer Ingelheim International GmbH
  • 15.3. Captek Softgel International Inc.
  • 15.4. Fuji Capsule Co. Ltd.
  • 15.5. Haleon PLC
  • 15.6. Johnson & Johnson
  • 15.7. Novartis AG
  • 15.8. Perrigo Company plc
  • 15.9. Reckitt Benckiser Group plc
  • 15.10. Robinson Pharma Inc.
  • 15.11. Sanofi SA
  • 15.12. Soft Gel Technologies Inc.
  • 15.13. Sun Pharmaceutical Industries Ltd
  • 15.14. The Procter & Gamble Company

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Capsule Cold Medicine Market, Years Considered for the Study
  • FIGURE 2. Global Capsule Cold Medicine Market, Research Design
  • FIGURE 3. Global Capsule Cold Medicine Market, Research Framework
  • FIGURE 4. Global Capsule Cold Medicine Market, Data Triangulation
  • FIGURE 5. Global Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Capsule Cold Medicine Market Size, by Active Ingredient, 2025 vs 2032 (%)
  • FIGURE 7. Global Capsule Cold Medicine Market Size, by Active Ingredient, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Capsule Cold Medicine Market Size, by Dosage Strength, 2025 vs 2032 (%)
  • FIGURE 9. Global Capsule Cold Medicine Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Capsule Cold Medicine Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 11. Global Capsule Cold Medicine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Capsule Cold Medicine Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Capsule Cold Medicine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Capsule Cold Medicine Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Capsule Cold Medicine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Capsule Cold Medicine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Capsule Cold Medicine Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Capsule Cold Medicine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Capsule Cold Medicine Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Capsule Cold Medicine Market Segmentation & Coverage
  • TABLE 2. Global Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 4. Global Combination Formulation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Combination Formulation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Combination Formulation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Acetaminophen Chlorpheniramine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Acetaminophen Chlorpheniramine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Acetaminophen Chlorpheniramine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Acetaminophen Phenylephrine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Acetaminophen Phenylephrine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Acetaminophen Phenylephrine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Ibuprofen Phenylephrine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Ibuprofen Phenylephrine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Ibuprofen Phenylephrine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Single Ingredient Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Single Ingredient Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Single Ingredient Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Acetaminophen Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Acetaminophen Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Acetaminophen Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Chlorpheniramine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Chlorpheniramine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Chlorpheniramine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Ibuprofen Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Ibuprofen Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Ibuprofen Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Phenylephrine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Phenylephrine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Phenylephrine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 32. Global High Dose >500 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global High Dose >500 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global High Dose >500 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Low Dose 0-200 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Low Dose 0-200 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Low Dose 0-200 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Medium Dose 201-500 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Medium Dose 201-500 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Medium Dose 201-500 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 42. Global Convenience Store Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Convenience Store Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Convenience Store Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Online Retail Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Online Retail Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Online Retail Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Supermarket Hypermarket Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Supermarket Hypermarket Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Supermarket Hypermarket Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 61. Global Adult Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Adult Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Adult Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Asia-Pacific Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Asia-Pacific Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 73. Asia-Pacific Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 74. Asia-Pacific Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 75. Asia-Pacific Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 76. Asia-Pacific Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 77. Asia-Pacific Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 78. Asia-Pacific Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 79. North America Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. North America Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 81. North America Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 82. North America Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 83. North America Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 84. North America Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 85. North America Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 86. North America Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 87. Latin America Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Latin America Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 89. Latin America Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 90. Latin America Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 91. Latin America Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 92. Latin America Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 93. Latin America Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 94. Latin America Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 95. Europe Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Europe Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 97. Europe Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 98. Europe Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 99. Europe Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 100. Europe Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 101. Europe Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 102. Europe Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 103. Middle East Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Middle East Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 105. Middle East Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 106. Middle East Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 107. Middle East Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 108. Middle East Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 109. Middle East Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 110. Middle East Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 111. Africa Capsule Cold Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Africa Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 113. Africa Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 114. Africa Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 115. Africa Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 116. Africa Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 117. Africa Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 118. Africa Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 119. Global Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. ASEAN Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. ASEAN Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 122. ASEAN Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 123. ASEAN Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 124. ASEAN Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 125. ASEAN Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 126. ASEAN Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 127. ASEAN Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 128. GCC Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 129. GCC Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 130. GCC Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 131. GCC Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 132. GCC Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 133. GCC Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 134. GCC Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 135. GCC Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 136. European Union Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 137. European Union Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 138. European Union Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 139. European Union Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 140. European Union Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 141. European Union Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 142. European Union Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 143. European Union Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 144. BRICS Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 145. BRICS Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 146. BRICS Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 147. BRICS Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 148. BRICS Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 149. BRICS Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 150. BRICS Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 151. BRICS Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 152. G7 Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 153. G7 Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 154. G7 Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 155. G7 Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 156. G7 Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 157. G7 Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 158. G7 Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 159. G7 Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. NATO Capsule Cold Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 161. NATO Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 162. NATO Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 163. NATO Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 164. NATO Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 165. NATO Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 166. NATO Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 167. NATO Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 168. Global Capsule Cold Medicine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 169. United States Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 170. United States Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 171. United States Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 172. United States Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 173. United States Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 174. United States Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 175. United States Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 176. United States Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 177. Canada Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 178. Canada Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 179. Canada Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 180. Canada Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 181. Canada Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 182. Canada Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Canada Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 184. Canada Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 185. Mexico Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 186. Mexico Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 187. Mexico Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 188. Mexico Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 189. Mexico Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 190. Mexico Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 191. Mexico Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 192. Mexico Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 193. Brazil Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 194. Brazil Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 195. Brazil Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 196. Brazil Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 197. Brazil Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 198. Brazil Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 199. Brazil Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 200. Brazil Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. United Kingdom Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 202. United Kingdom Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 203. United Kingdom Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 204. United Kingdom Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 205. United Kingdom Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 206. United Kingdom Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 207. United Kingdom Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 208. United Kingdom Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. Germany Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 210. Germany Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 211. Germany Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 212. Germany Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 213. Germany Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 214. Germany Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 215. Germany Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 216. Germany Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 217. France Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 218. France Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 219. France Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 220. France Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 221. France Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 222. France Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 223. France Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 224. France Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 225. Russia Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 226. Russia Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 227. Russia Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 228. Russia Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 229. Russia Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 230. Russia Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 231. Russia Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 232. Russia Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Italy Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 234. Italy Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 235. Italy Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 236. Italy Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 237. Italy Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 238. Italy Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 239. Italy Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 240. Italy Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 241. Spain Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 242. Spain Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 243. Spain Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 244. Spain Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 245. Spain Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 246. Spain Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 247. Spain Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 248. Spain Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 249. China Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 250. China Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 251. China Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 252. China Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 253. China Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 254. China Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 255. China Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 256. China Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 257. India Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 258. India Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 259. India Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 260. India Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 261. India Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 262. India Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 263. India Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 264. India Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 265. Japan Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 266. Japan Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 267. Japan Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 268. Japan Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 269. Japan Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 270. Japan Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 271. Japan Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 272. Japan Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 273. Australia Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 274. Australia Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 275. Australia Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 276. Australia Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 277. Australia Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 278. Australia Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 279. Australia Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 280. Australia Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 281. South Korea Capsule Cold Medicine Market Size, 2017-2032 (USD Million)
  • TABLE 282. South Korea Capsule Cold Medicine Market Size, by Active Ingredient, 2017-2032 (USD Million)
  • TABLE 283. South Korea Capsule Cold Medicine Market Size, by Combination Formulation, 2017-2032 (USD Million)
  • TABLE 284. South Korea Capsule Cold Medicine Market Size, by Single Ingredient, 2017-2032 (USD Million)
  • TABLE 285. South Korea Capsule Cold Medicine Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 286. South Korea Capsule Cold Medicine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 287. South Korea Capsule Cold Medicine Market Size, by Pharmacy, 2017-2032 (USD Million)
  • TABLE 288. South Korea Capsule Cold Medicine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 289. Global Capsule Cold Medicine Market Share, by Key Player, 2025
  • TABLE 290. Global Capsule Cold Medicine Market, Key Experts